Literature DB >> 2471782

Host cell selection of antigenic variants of foot-and-mouth disease virus.

C Bolwell1, A L Brown, P V Barnett, R O Campbell, B E Clarke, N R Parry, E J Ouldridge, F Brown, D J Rowlands.   

Abstract

Foot-and-mouth disease virus (FMDV) A22 Iraq 24/64 adapted to grow in BHK monolayer cells induced antibodies which neutralized many isolates belonging to the A serotype. Plaque-purified virus isolated from this stock also induced broadly reactive antibodies, showing that this property is not due to the combined response to a mixture of variants in the original stock virus. However, viruses obtained by passage in suspension BHK cells of either the monolayer cell-adapted virus or a virus cloned from this stock resulted in the selection of virus which induced antibodies with highly specific neutralizing activity. In addition to their antigenic properties the monolayer and suspension cell-adapted viruses could be distinguished by plaque morphology, tendency to aggregate and ability to attach to BHK cells. Monoclonal antibodies (MAbs) induced with the plaque-purified monolayer-adapted virus had neutralizing activity almost as broad as polyclonal serum, showing that this property can be represented by a single epitope on the virus. These neutralizing MAbs recognize a trypsin-sensitive epitope on the virus. Surprisingly, sequence analysis of the structural protein-coding regions of the genomic RNAs of monolayer and suspension cell-adapted viruses showed no amino acid differences in VP1, the protein known to contain the major neutralization epitope in FMDV and to be the only protein susceptible to cleavage by trypsin in the virus particle. Although three coding differences were found in the capsid protein these were all located in VP2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471782     DOI: 10.1099/0022-1317-70-1-45

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.

Authors:  T Jackson; A Sharma; R A Ghazaleh; W E Blakemore; F M Ellard; D L Simmons; J W Newman; D I Stuart; A M King
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.

Authors:  J C Saiz; M J Gonzalez; M V Borca; F Sobrino; D M Moore
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor.

Authors:  S Neff; D Sá-Carvalho; E Rieder; P W Mason; S D Blystone; E J Brown; B Baxt
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.

Authors:  J Chinsangaram; C Beard; P W Mason; M K Zellner; G Ward; M J Grubman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle.

Authors:  D Sa-Carvalho; E Rieder; B Baxt; R Rodarte; A Tanuri; P W Mason
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus.

Authors:  J M Katz; M Wang; R G Webster
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

8.  Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle.

Authors:  Elizabeth Rieder; Tina Henry; Hernando Duque; Barry Baxt
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

9.  Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture.

Authors:  E Rieder; B Baxt; P W Mason
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  The capsid protein-encoding sequence of foot-and-mouth disease virus O2Brescia.

Authors:  O Krebs; H G Berger; O Marquardt
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.